Business
Press Release Aug 17 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 17, 2023, titled "Zydus receives final approval from the USFDA for Doxepin Tablets, 3 mg and 6 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 17, 2023, titled \"Zydus receives final approval from the USFDA for Doxepin Tablets, 3 mg and 6 mg\". View Attachment","length":345,"tagName":"div"}]